Herpes zoster ophthalmicus in COVID-19 patients

Int J Dermatol. 2020 Dec;59(12):1545-1546. doi: 10.1111/ijd.15240. Epub 2020 Oct 11.

Authors

Ahmad Nofal^{1

2}, Mohamed M Fawzy^{2

3}, Sherif M Sharaf El Deen⁴, Esraa E El-Hawary³

Affiliations

¹ Dermatology, Venereology and Andrology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
² Member of Interactive Dermatology Research Group, Cairo, Egypt.
³ Dermatology, Venereology and Andrology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
⁴ Ophthalmology Department, Zagazig University, Zagazig, Egypt.

No abstract available

Keywords: COVID-19; herpes zoster; ocular involvement.

Publication types

Case Reports
Letter

MeSH terms

Acyclovir / administration & dosage
Administration, Cutaneous
Administration, Oral
Adult
Antiviral Agents / administration & dosage*
Betacoronavirus / immunology*
Betacoronavirus / isolation & purification
COVID-19
Child
Coronavirus Infections / complications*
Coronavirus Infections / diagnosis
Coronavirus Infections / immunology
Coronavirus Infections / virology
Drug Therapy, Combination / methods
Female
Herpes Zoster Ophthalmicus / diagnosis*
Herpes Zoster Ophthalmicus / drug therapy
Herpes Zoster Ophthalmicus / immunology
Herpes Zoster Ophthalmicus / virology
Herpesvirus 3, Human / immunology*
Herpesvirus 3, Human / isolation & purification
Humans
Male
Ophthalmic Solutions / administration & dosage
Pandemics
Pneumonia, Viral / complications*
Pneumonia, Viral / diagnosis
Pneumonia, Viral / immunology
Pneumonia, Viral / virology
Prednisolone / administration & dosage
Prednisolone / analogs & derivatives
SARS-CoV-2
Treatment Outcome
Virus Activation / immunology

Substances

Antiviral Agents
Ophthalmic Solutions
prednisolone acetate
Prednisolone
Acyclovir